ARCH Venture Management as of Dec. 31, 2022
Portfolio Holdings for ARCH Venture Management
ARCH Venture Management holds 8 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Denali Therapeutics (DNLI) | 26.1 | $102M | 3.7M | 27.81 | |
| Karuna Therapeutics Ord | 25.8 | $101M | 513k | 196.50 | |
| Eqrx | 22.9 | $89M | 36M | 2.46 | |
| Erasca (ERAS) | 12.2 | $48M | 11M | 4.31 | |
| Verve Therapeutics (VERV) | 10.0 | $39M | 2.0M | 19.35 | |
| Singular Genomics Systems In | 2.0 | $7.6M | 3.8M | 2.01 | |
| Unity Biotechnology (UBX) | 0.7 | $2.8M | 1.0M | 2.74 | |
| Metacrine Ord | 0.3 | $1.3M | 2.9M | 0.45 |
